Trial Profile
Comparison of thrice daily insulin aspart and thrice daily insulin aspart 70/30 on glycemic control and safety in type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Insulin aspart
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 03 Jun 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan records.
- 12 Jan 2012 New trial record